4d Molecular Therapeutics, Inc. · NASDAQ:FDMT

BlackRock, Inc. reported a 6.60% stake in 4d Molecular Therapeutics, Inc. (Schedule 13G/A)

Event Sep 30, 2025 · Filed Oct 17, 2025

BlackRock, Inc. reported a 6.60% stake in 4d Molecular Therapeutics, Inc., 3,062,596 shares, as a passive investor on Sep 30, 2025. Filed Oct 17, 2025 (Schedule 13G/A).

Stake
6.60%
Shares
3,062,596
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BlackRock, Inc.6.60%3,062,596

Source

View original at SEC

Related